I thought that cobicistat is needed because of the elvitegravir component which needs to be taken twice a day if not boosted. If a competitor has an integrase inhibitor such as dolutegravir that can be dosed once-a-day without boosting, then they would not need cobicistat.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.